Skip to content

Clinical trials

Completed Multiple Myeloma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: United Kingdom Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20033
20041
20052
20065
20072
20084
20095
20107
20115
20129
20135
20149
20158
20165
20177
20186
20192
20203
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene14
Janssen Research & Development, LLC11
Amgen8
GlaxoSmithKline6
Millennium Pharmaceuticals, Inc.4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Pfizer3
Royal Marsden NHS Foundation Trust3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma100
Recurrence15
Neoplasms, Plasma Cell13
Neoplasms9
Lymphoma6
Leukemia5
Renal Insufficiency5
Leukemia, Myeloid, Acute4
Lymphoma, B-Cell4
Breast Neoplasms3

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.